This programme has been organised by PCUS and funded by Astellas Pharma Ltd. Astellas Pharma Ltd was not involved in the development of the programme, content, selection of speakers or their arrangements, with the exception of the sponsored symposium sessions, which have been developed and delivered by Astellas Pharma Ltd.
.jpg)
During the transition from reproductive to post-reproductive years, many women attribute vaginal and urinary changes to the natural process of aging, rather than recognising associated symptoms as potential indicators of genitourinary syndrome of the menopause. As symptoms are often delayed by years post-menopause, women may not suspect menopause and hormonal changes as the underlying cause.
Join the Primary Care Urology Society on Tuesday 1st December 2026, 19:00–20:40, for Beyond the Bladder: Urogenital Health in Primary Care, a free evening webinar to support timely diagnosis in primary care, with live Q&A. Register now to secure your place.
Welcome & Introduction
Genito-urinary syndrome of the menopause (incl. Q&A)
Improving outcomes for people living with overactive bladder (OAB): the role of primary care in optimising treatment and reducing anticholinergic burden
This sponsored symposium is funded by Astellas Pharma Ltd.
MAT-GB-MIR-2026-00200 | October 2026
Closing remarks
This site is intended for use by UK healthcare professionals.
Please select the appropriate option below.